Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas

Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):625-8. doi: 10.1055/s-2008-1065366. Epub 2008 May 16.

Abstract

Objective: Recent data suggest that mutations in the aryl hydrocarbon receptor interacting protein gene (AIP) are associated with pituitary adenomas. AIP is considered to be a tumour suppressor gene.

Methods: 110 Caucasian patients living in Germany with pituitary adenoma (55 hormone secreting, 55 non-functioning) were examined for AIP mutations.

Results: Three patients (2.7%) harboured an AIP germline mutation. A heterozygous mutation, R16H (c.47G>A), was found in two patients and a heterozygous G>C change in the 3'UTR, 60 bp downstream of the termination codon, in one patient. All three patients suffered from non-functioning adenoma. Additionally, a silent polymorphism, D172D (c.516C>T), was found in 3 patients with non-functioning adenoma, in 2 patients with prolactinoma and in one patient with acromegaly.

Conclusions: AIP mutations are rare in sporadic pituitary adenomas in the German population and occur independently from a hormone secretion of the adenoma.

MeSH terms

  • Adenoma / genetics*
  • Adenoma / metabolism*
  • Adult
  • Age of Onset
  • Aged
  • Amino Acid Substitution
  • Chromosome Mapping
  • Chromosomes, Human, Pair 11*
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Pedigree
  • Pituitary Hormones / metabolism
  • Pituitary Neoplasms / genetics*
  • Pituitary Neoplasms / metabolism*

Substances

  • Intracellular Signaling Peptides and Proteins
  • Pituitary Hormones
  • aryl hydrocarbon receptor-interacting protein